Retinoic acid-induced neuronal differentiation regulates expression of mRNAs for neurotrophins and neurotrophin receptors in a human embryonal carcinoma cell line NTera2

Neuropathology

Volumn 17, Issue 2, 1997, Pages 80-88

  Satoh, Jun Ichi ^a   Yukitake, Motohiro ^a   Kurohara, Kazuhiro ^a   Kuroda, Yasuo ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Neuronal differentiation; Neurotrophin receptors; Neurotrophins; NTera2 cells; Retinoic acid

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; NEUROTROPHIN RECEPTOR; RETINOIC ACID;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; EMBRYO; EMBRYONAL CARCINOMA; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

EID: 0030801415     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1789.1997.tb00018.x     Document Type: Article

References (15)

1. Glass DJ, Yancopoulos GD. The neuotrophins and their receptors. Trends Cell Biol. 1993; 3: 262-268.
2. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995; 270:593-598.
3. Chao MV, Hempstead BL. p75 and Trk: a two-receceptor system. Trends Neurosci. 1995; 18: 321-326.
4. Glass DJ, Nye SH, Hantzopoulos P et al. TrkB mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor. Cell 1991; 66:405-413.
5. Hantzopoulos PA, Suri C, Glass DJ, Goldfarb MP, Yancopoulos GD. The low affinity NGF receptor, p75, can collaborate with each of the Trks to potentiate functional responses to the neurotrophins. Neuron 1994; 13: 187-201.
6. Hartikka J, Hefti F. Development of septal cholinergic neurons in culture: plating density and glial cells modulate effects of NGF on survival, fiber growth, and expression of transmitter-specific enzymes. J. Neurosci. 1988; 8: 2967-2985.
7. Maisonpierre PC, Belluscio L, Friedman B et al. NT-3, BDNF, and NGF in the developing rat nervous system: parallel as well as reciprocal patterns of expression. Neuron 1990; 5:501-509.
8. Phillips HS, Hains JM, Laramee GR, Rosenthal A, Winslow JW. Widespread expression of BDNF but not NT-3 by target areas of basal forebrain cholinergic neurons. Science 1990; 250: 290-294.
9. Hyman C, Hofer M, Barde Y-A et al. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 1991; 350: 230-232.
10. Knüsel B, Winslow JW, Rosenthal A et al. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc. Natl Acad. Sci. USA 1991; 88: 961-965.
11. DiStefano PS, Friedman B, Radziejewski C et al. The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron 1992; 8:983-993.
12. Friedman B, Kleinfeld D, Ip NY et al. BDNF and NT-4/5 exert neurotrophic influences on injured adult spinal motor neurons. J. Neurosci. 1995; 15: 1044-1056.
13. Gao W-Q, Zheng JL, Karihaloo M. Neurotrophin-4/5 (NT-4/5) and brain-derived neurotrophic factor (BDNF) act at later stages of cerebellar granule cell differentiation. J. Neurosci. 1995; 15: 2656-2667.
14. Schätzl HM. Neurotrophic factors: ready to go? Trends Neurosci. 1995; 18:463-464.
15. Yuen EC, Mobley WC. Therapeutic applications of neurotrophic factors in disorders of motor neurons and peripheral nerves. Mol. Med. Today 1995; 1:278-286.